These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 11493313)
1. Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells. Kivinen PK; Kaminska R; Naukkarinen A; Harvima RJ; Horsmanheimo M; Harvima IT Exp Dermatol; 2001 Aug; 10(4):246-55. PubMed ID: 11493313 [TBL] [Abstract][Full Text] [Related]
2. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors. Huttunen M; Harvima IT Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975 [TBL] [Abstract][Full Text] [Related]
3. The release of histamine is associated with the inactivation of mast cell chymase during immediate allergic wheal reaction in the skin. Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT Clin Exp Allergy; 2001 Apr; 31(4):593-601. PubMed ID: 11359428 [TBL] [Abstract][Full Text] [Related]
4. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection. Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866 [TBL] [Abstract][Full Text] [Related]
5. Mast cell tryptase and chymase in developing and mature psoriatic lesions. Harvima IT; Naukkarinen A; Paukkonen K; Harvima RJ; Aalto ML; Schwartz LB; Horsmanheimo M Arch Dermatol Res; 1993; 285(4):184-92. PubMed ID: 8342961 [TBL] [Abstract][Full Text] [Related]
6. Decreased chymase activity is associated with increased levels of protease inhibitors in mast cells of psoriatic lesions. Harvima IT; Haapanen L; Ackermann L; Naukkarinen A; Harvima RJ; Horsmanheimo M Acta Derm Venereol; 1999 Mar; 79(2):98-104. PubMed ID: 10228625 [TBL] [Abstract][Full Text] [Related]
7. The increase in tryptase- and chymase-positive mast cells is associated with partial inactivation of chymase and increase in protease inhibitors in basal cell carcinoma. Diaconu NC; Kaminska R; Naukkarinen A; Harvima RJ; Harvima IT J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):908-15. PubMed ID: 17658999 [TBL] [Abstract][Full Text] [Related]
8. Mast cell chymase and tryptase during tissue turnover: analysis on in vitro mitogenesis of fibroblasts and keratinocytes and alterations in cutaneous scars. Algermissen B; Hermes B; Feldmann-Boeddeker I; Bauer F; Henz BM Exp Dermatol; 1999 Jun; 8(3):193-8. PubMed ID: 10389636 [TBL] [Abstract][Full Text] [Related]
9. Mast cell tryptase and chymase in the progress of cutaneous vasculitis. Lipitsä T; Naukkarinen A; Harvima IT Arch Dermatol Res; 2015 Dec; 307(10):917-24. PubMed ID: 26498154 [TBL] [Abstract][Full Text] [Related]
10. Compound 48/80-induced secretion of histamine from rat peritoneal mast cells depends on a tryptase controlled step also leading to chymase activity. Vassimon CS; Rothschild AM Agents Actions; 1990 Apr; 30(1-2):150-2. PubMed ID: 1695438 [TBL] [Abstract][Full Text] [Related]
11. Alterations in mast cells showing tryptase and chymase activity in epithelializating and chronic wounds. Huttunen M; Aalto ML; Harvima RJ; Horsmanheimo M; Harvima IT Exp Dermatol; 2000 Aug; 9(4):258-65. PubMed ID: 10949547 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-4-positive mast cells are highly associated with the extent of immediate allergic wheal reaction in the skin. Saarinen JV; Harvima RJ; Naukkarinen A; Horsmanheimo M; Harvima IT Allergy; 2001 Jan; 56(1):58-64. PubMed ID: 11167353 [TBL] [Abstract][Full Text] [Related]
13. Quantitative enzyme-histochemical analysis of tryptase- and chymase-containing mast cells in psoriatic skin. Harvima IT; Naukkarinen A; Harvima RJ; Aalto ML; Neittaanmäki H; Horsmanheimo M Arch Dermatol Res; 1990; 282(7):428-33. PubMed ID: 1706585 [TBL] [Abstract][Full Text] [Related]
14. Mast cells in developing subepidermal bullous diseases: emphasis on tryptase, chymase and protease inhibitors. Kaminska R; Naukkarinen A; Glinski W; Horsmanheimo M; Harvima IT Acta Derm Venereol; 1999 Sep; 79(5):351-5. PubMed ID: 10494709 [TBL] [Abstract][Full Text] [Related]
16. Altered expression of mast cell chymase and tryptase and of c-Kit in human cutaneous scar tissue. Hermes B; Feldmann-Böddeker I; Welker P; Algermissen B; Steckelings MU; Grabbe J; Henz BM J Invest Dermatol; 2000 Jan; 114(1):51-5. PubMed ID: 10620115 [TBL] [Abstract][Full Text] [Related]
17. The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitors. He S; Gaça MD; Walls AF Eur J Pharmacol; 2001 Feb; 412(3):223-9. PubMed ID: 11166285 [TBL] [Abstract][Full Text] [Related]
18. Enzyme histochemical discrimination between tryptase and chymase in mast cells of human gut. Osman IA; Garrett JR; Smith RE J Histochem Cytochem; 1989 Apr; 37(4):415-21. PubMed ID: 2647838 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms of nonimmunological histamine and tryptase release from human cutaneous mast cells. Veien M; Szlam F; Holden JT; Yamaguchi K; Denson DD; Levy JH Anesthesiology; 2000 Apr; 92(4):1074-81. PubMed ID: 10754628 [TBL] [Abstract][Full Text] [Related]
20. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin. Naukkarinen A; Harvima IT; Aalto ML; Horsmanheimo M Int J Dermatol; 1994 May; 33(5):361-6. PubMed ID: 8039976 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]